Journal: Translational Cancer Research
Article Title: The effect and related mechanisms of RAC1 GTP on radiotherapy for hepatocellular carcinoma
doi: 10.21037/tcr-2025-987
Figure Lengend Snippet: Expression of RAC1 mRNA and its protein levels. (A,B) Expression of RAC1 mRNA in tumor tissues and adjacent tissues. (C) Expression of RAC1 mRNA in different stages of tumors. (D,E) Immunohistochemical analysis of RAC1 expression in tumor tissues and adjacent tissues. (F) Comparison of differences in RAC1 expression between tumor tissues and adjacent tissues. *, P<0.05; **, P<0.01; ****, P<0.0001. ns, not significant; LIHC, liver hepatocellular carcinoma; RAC1 , Ras-related C3 botulinum toxin substrate 1; TPM, transcripts per million.
Article Snippet: The following immunochemical reagents were employed: rabbit monoclonal anti-RAC1 antibody (clone ARC03;cCat #CY-2103; CytoSkeleton, Inc., Denver, CO, USA), phospho-IκBα (Ser32) antibody [Cat #2859S; Cell Signaling Technology (CST), Inc., Danvers, MA, USA], IκBα antibody (Cat #4814S; CST), and rabbit polyclonal Bcl-xL antibody (clone ARC0183; Cat #A19703; ABclonal Technology Co., Ltd., Woburn, MA, USA).
Techniques: Expressing, Immunohistochemical staining, Comparison